Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Phreesia, Inc. Common Stock (NY:PHR)

20.31 +0.26 (+1.30%)
Streaming Delayed Price Updated: 11:34 AM EST, Nov 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Phreesia, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Capricorn Fund Loads Up on Phreesia (PHR) With a 484,000 Share Purchase ↗
Capricorn Fund Loads Up on Phreesia (PHR) With a 484,000 Share Purchase 
Via The Motley Fool
News headline image
Phreesia Analysts Raise Their Forecasts After Q2 Results ↗
 
Via Benzinga
News headline image
Analysts Weigh Integration Risks As Phreesia Expands With New Deal ↗
Phreesia gains analyst support with price target hikes, though integration risks and modest guidance raise tempered investor enthusiasm. 
Via Benzinga
News headline image
Beyond The Numbers: 6 Analysts Discuss Phreesia Stock ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
An Overview of Phreesia's Earnings ↗
 
Via Benzinga
News headline image
Where Phreesia Stands With Analysts ↗
 
Via Benzinga
News headline image
What to Expect from Phreesia's Earnings ↗
 
Via Benzinga
News headline image
Phreesia PHR Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
Phreesia Reports First Net Income Gain ↗
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
These stocks are moving in today's after hours session ↗
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Phreesia Posts 15% Revenue Gain in Q2 ↗
Via The Motley Fool
News headline image
Earnings Scheduled For September 4, 2025 ↗
 
Via Benzinga
News headline image
3 Red-Hot Growth Stocks to Buy in 2025 ↗
Via The Motley Fool
Topics Retirement
News headline image
What 4 Analyst Ratings Have To Say About Phreesia ↗
 
Via Benzinga
News headline image
Q1 Earnings Outperformers: Phreesia (NYSE:PHR) And The Rest Of The Healthcare Technology for Providers Stocks
Looking back on healthcare technology for providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Phreesia (NYSE:PHR) and its peers. 
Via StockStory
News headline image
PHR Q1 Earnings Call: Profitability Surges Amid Product Expansion
Healthcare technology company Phreesia (NYSE:PHR) exceeded Wall Street’s revenue expectations in Q1 CY2025, as sales rose 14.5% year on year to $115.9 million. Its GAAP loss of $0.07 per share... 
Via StockStory
Topics Artificial Intelligence
News headline image
PHR Q1 Earnings Call: Revenue Misses, Profitability Surges Amid Product Expansion
Healthcare technology company Phreesia (NYSE:PHR) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 14.5% year on year to $115.9 million. Its GAAP loss of $0.07 per share increased... 
Via StockStory
Topics Artificial Intelligence
News headline image
Phreesia (NYSE:PHR) Surprises With Q1 Sales
Healthcare technology company Phreesia (NYSE:PHR) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 14.5% year on year to $115.9 million. The company expects the... 
Via StockStory
News headline image
Earnings Scheduled For May 28, 2025 ↗
 
Via Benzinga
News headline image
Phreesia (PHR) Reports Q1: Everything You Need To Know Ahead Of Earnings
Healthcare technology company Phreesia (NYSE:PHR) will be reporting results tomorrow after market hours. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
News headline image
3 of Wall Street’s Favorite Stocks Skating on Thin Ice
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
News headline image
1 Cash-Heavy Stock with Impressive Fundamentals and 2 to Ignore
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,... 
Via StockStory
News headline image
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (NYSE:EVH) and... 
Via StockStory
News headline image
Unpacking Q4 Earnings: Omnicell (NASDAQ:OMCL) In The Context Of Other Healthcare Technology for Providers Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Omnicell (NASDAQ:OMCL) and the best and... 
Via StockStory
News headline image
Q4 Earnings Highs And Lows: Premier (NASDAQ:PINC) Vs The Rest Of The Healthcare Technology for Providers Stocks
Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Premier (NASDAQ:PINC) and its peers. 
Via StockStory
Topics Economy
News headline image
Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers
Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season. 
Via StockStory
News headline image
Q4 Rundown: Astrana Health (NASDAQ:ASTH) Vs Other Healthcare Technology for Providers Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers. 
Via StockStory
News headline image
Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks
Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season. 
Via StockStory
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.